home / stock / crlbf / crlbf articles
The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal l...
The AdvisorShares Pure US Cannabis ETF (NASDAQ: MSOS) surged by more than 14% on Thursday as the whole cannabis sector experien...
As the marijuana industry continues to evolve and gain momentum across the United States, two governors stand out for their significant contributio...
It’s still cannabis earnings season, but we’re also turning to look at some of the news from the psychedelics industry. This Trade To ...
News, Short Squeeze, Breakout and More Instantly...
The Cannabis Regulators Association (CANNRA) is requesting that the U.S. Drug Enforcement Administration and Biden Administration offer clarity on how rescheduling cannabis will affect enforcement by the federal government, particularly in legal states. In a public comment to the DEA’s ...
Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial ...
2024-07-20 11:00:59 ET US Marijuana Penny Stocks to Watch for Explosive Growth in August The U.S. cannabis industry and marijuana stocks are growing rapidly, with a market size expected to reach $41.5 billion by 2025. This growth is driven by increasing legalization and consumer dem...